Serebral Palside Endokrinolojik İzlem

Andrew, M. J., & Sullivan, P. B. (2010). Growth in cerebral palsy. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 25(4), 357–361.

Alikaşifoğlu A, S: Erken Puberte. İç: Darendeliler F, Aycan Z, Kara C, Özen S, Eren E ed. Çocuk Endokrinolojisi ve Diyabet. 1.baskı İstanbul Tıp; 2021: 688-701.

Ali, O., Shim, M., Fowler, E., Greenberg, M., Perkins, D., Oppenheim, W., & Cohen, P. (2007). Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study. The Journal of clinical endocrinology and metabolism, 92(3), 932–937.

Alvarez Zaragoza, C., Vasquez Garibay, E. M., García Contreras, A. A., Larrosa Haro, A., Romero Velarde, E., Rea Rosas, A., Cabrales de Anda, J. L., & Vega Olea, I. (2018). Bone mineral density and nutritional status in children with quadriplegic cerebral palsy. Archives of osteoporosis, 13(1), 17.

Barbier, V., Goeb, V., Gouron, R., Fritot, S., Mentaverri, R., & Klein, C. (2023). Bone health in children with severe cerebral palsy. Frontiers in pediatrics, 11, 1264111.

Barthold, J. S., Wintner, A., Hagerty, J. A., Rogers, K. J., & Hossain, M. J. (2018). Cryptorchidism in Boys With Cerebral Palsy Is Associated With the Severity of Disease and With Co-Occurrence of Other Congenital Anomalies. Frontiers in endocrinology, 9, 151.

Benedetti, M. S., Whomsley, R., Baltes, E., & Tonner, F. (2005). Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. European journal of clinical pharmacology, 61(12), 863–872.

Brooks, J., Day, S., Shavelle, R., & Strauss, D. (2011). Low weight, morbidity, and mortality in children with cerebral palsy: new clinical growth charts. Pediatrics, 128(2), e299–e307.

Bruzzi, P., Messina, M. F., Bartoli, A., Predieri, B., Lucaccioni, L., Madeo, S. F., Verrotti, A., De Luca, F., & Iughetti, L. (2017). Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study. International journal of endocrinology, 2017, 4807163.

Castro-Gago, M., Novo-Rodríguez, M. I., Gómez-Lado, C., Rodríguez-García, J., Rodríguez-Segade, S., & Eirís-Puñal, J. (2007). Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs. Pediatric neurology, 37(6), 426–430.

Chen, C. L., Ke, J. Y., Lin, K. C., Wang, C. J., Wu, C. Y., & Liu, W. Y. (2011). Anthropometric and fitness variables associated with bone mineral density and broadband ultrasound attenuation in ambulatory children with cerebral palsy. Journal of child neurology, 26(5),

Chumlea, W. C., Guo, S. S., & Steinbaugh, M. L. (1994). Prediction of stature from knee height for black and white adults and children with application to mobility-impaired or handicapped persons. Journal of the American Dietetic Association, 94(12), 1385–1390.

Committee on Adolescence (2014). Contraception for adolescents. Pediatrics, 134(4), e1244–e1256.

Compston J. E. (2001). Sex steroids and bone. Physiological reviews, 81(1), 419–447.

Cortada, X., & Kousseff, B. G. (1984). Cryptorchidism in mental retardation. The Journal of urology, 131(4), 674–676.

Coniglio, S. J., Stevenson, R. D., & Rogol, A. D. (1996). Apparent growth hormone deficiency in children with cerebral palsy. Developmental medicine and child neurology, 38(9), 797–804.

Day, S. M., Strauss, D. J., Vachon, P. J., Rosenbloom, L., Shavelle, R. M., & Wu, Y. W. (2007). Growth patterns in a population of children and adolescents with cerebral palsy. Developmental medicine and child neurology, 49(3), 167–171.

Devesa, J., Casteleiro, N., Rodicio, C., López, N., & Reimunde, P. (2010). Growth hormone deficiency and cerebral palsy. Therapeutics and clinical risk management, 6, 413–418.

Devesa, J., Alonso, B., Casteleiro, N., Couto, P., Castañón, B., Zas, E., & Reimunde, P. (2011). Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study. Therapeutics and clinical risk management, 7, 199–206.

Emeksiz HC, Bideci A, S: Puberte fizyolojisi. İç: Darendeliler F, Aycan Z, Kara C, Özen S, Eren E ed. Çocuk Endokrinolojisi ve Diyabet. 1.baskı İstanbul Tıp; 2021: 652-675

Florencio-Silva, R., Sasso, G. R., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S. (2015). Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. BioMed research international, 2015, 421746.

Frost H. M. (2003). Bone’s mechanostat: a 2003 update. The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology, 275(2), 1081–1101.

Gill, B., & Kogan, S. (1997). Cryptorchidism. Current concepts. Pediatric clinics of North America, 44(5), 1211–1227.

Glickman, L. B., Geigle, P. R., & Paleg, G. S. (2010). A systematic review of supported standing programs. Journal of pediatric rehabilitation medicine, 3(3), 197–213.

Gold, M. A., & Duffy, K. (2009). Extended cycling or continuous use of hormonal contraceptives for female adolescents. Current opinion in obstetrics & gynecology, 21(5), 407–411.

Grover S. R. (2002). Menstrual and contraceptive management in women with an intellectual disability. The Medical journal of Australia, 176(3), 108–110.

Grover S. R. (2011). Gynaecological issues in adolescents with disability. Journal of paediatrics and child health, 47(9), 610–613.

Güngör, O., Özkaya, A. K., & Temiz, F. (2020). The effect of antiepileptic drugs on thyroid hormonal function: valproic acid and phenobarbital. Acta neurologica Belgica, 120(3), 615–619.

Harper, L., Michel, J. L., & De Napoli-Cocci, S. (2010). Should we perform orchidopexy for cryptorchidism in children with severe encephalopathy?. Journal of pediatric urology, 6(3), 274–276.

Henderson, R. C., Lin, P. P., & Greene, W. B. (1995). Bone-mineral density in children and adolescents who have spastic cerebral palsy. The Journal of bone and joint surgery. American volume, 77(11), 1671–1681.

Henderson, R. C., Lark, R. K., Gurka, M. J., Worley, G., Fung, E. B., Conaway, M., Stallings, V. A., & Stevenson, R. D. (2002). Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics, 110(1 Pt 1), e5.

Henderson, R. C., Gilbert, S. R., Clement, M. E., Abbas, A., Worley, G., & Stevenson, R. D. (2005). Altered skeletal maturation in moderate to severe cerebral palsy. Developmental medicine and child neurology, 47(4), 229–236.

Henderson, R. C., Kairalla, J. A., Barrington, J. W., Abbas, A., & Stevenson, R. D. (2005). Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy. The Journal of pediatrics, 146(6), 769–775.

Houlihan, C. M., & Stevenson, R. D. (2009). Bone density in cerebral palsy. Physical medicine and rehabilitation clinics of North America, 20(3), 493–508.

Isojärvi, J. I., Taubøll, E., Pakarinen, A. J., van Parys, J., Rättyä, J., Harbo, H. F., Dale, P. O., Fauser, B. C., Gjerstad, L., Koivunen, R., Knip, M., & Tapanainen, J. S. (2001). Altered ovarian function and cardiovascular risk factors in valproate-treated women. The American journal of medicine, 111(4), 290–296.

Jekovec-Vrhovsek, M., Kocijancic, A., & Prezelj, J. (2000). Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Developmental medicine and child neurolog. 42(6), 403-405

Kaplowitz, P., Bloch, C., & Section on Endocrinology, American Academy of Pediatrics (2016). Evaluation and Referral of Children With Signs of Early Puberty. Pediatrics, 137(1), 10.1542/peds.2015-3732.

Kaplowitz P. B. (2010). Delayed puberty. Pediatrics in review, 31(5), 189–195.

Kecskemethy HHBS. Managing Bone Fragility in the Child with Cerebral Palsy Cerebral Palsy Switzerlan. Cham: Springer; 2020. p. 371–93.

King, W., Levin, R., Schmidt, R., Oestreich, A., & Heubi, J. E. (2003). Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Developmental medicine and child neurology, 45(1).12-16.

Kirkham, Y. A., Allen, L., Kives, S., Caccia, N., Spitzer, R. F., & Ornstein, M. P. (2013). Trends in menstrual concerns and suppression in adolescents with developmental disabilities. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 53(3), 407–412.

Klein-Nulend, J., Bacabac, R. G., & Mullender, M. G. (2005). Mechanobiology of bone tissue. Pathologie-biologie, 53(10), 576–580.

Ko, A., Kong, J., Samadov, F., Mukhamedov, A., Kim, Y. M., Lee, Y. J., & Nam, S. O. (2020). Bone health in pediatric patients with neurological disorders. Annals of pediatric endocrinology & metabolism, 25(1), 15–23.

Kuperminc, M. N., Gurka, M. J., Houlihan, C. M., Henderson, R. C., Roemmich, J. N., Rogol, A. D., & Stevenson, R. D. (2009). Puberty, statural growth, and growth hormone release in children with cerebral palsy. Journal of pediatric rehabilitation medicine, 2(2), 131–141.

Leet, A. I., Mesfin, A., Pichard, C., Launay, F., Brintzenhofeszoc, K., Levey, E. B., & D Sponseller, P. (2006). Fractures in children with cerebral palsy. Journal of pediatric orthopedics, 26(5), 624–627.

Lidegaard, Ø., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., & Løkkegaard, E. (2011). Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ (Clinical research ed.), 343, d6423.

Löscher, W., & Schmidt, D. (1980). Increase of human plasma GABA by sodium valproate. Epilepsia, 21(6), 611–615.

Mäkitie, O., Doria, A. S., Henriques, F., Cole, W. G., Compeyrot, S., Silverman, E., Laxer, R., Daneman, A., & Sochett, E. B. (2005). Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. The Journal of pediatrics, 146(3), 395–401.

Mergler, S., Evenhuis, H. M., Boot, A. M., De Man, S. A., Bindels-De Heus, K. G., Huijbers, W. A., & Penning, C. (2009). Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review. Developmental medicine and child neurology, 51(10).773-778

Mikati, M. A., Tarabay, H., Khalil, A., Rahi, A. C., El Banna, D., & Najjar, S. (2007). Risk factors for development of subclinical hypothyroidism during valproic acid therapy. The Journal of pediatrics, 151(2), 178–181.

Mikkonen, K., Vainionpää, L. K., Pakarinen, A. J., Knip, M., Järvelä, I. Y., Tapanainen, J. S., & Isojärvi, J. I. (2004). Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology, 62(3), 445–450.

Mus-Peters, C. T. R., Huisstede, B. M. A., Noten, S., Hitters, M. W. M. G. C., van der Slot, W. M. A., & van den Berg-Emons, R. J. G. (2019). Low bone mineral density in ambulatory persons with cerebral palsy? A systematic review. Disability and rehabilitation, 41(20), 2392–2402.

Oftedal, S., Davies, P. S., Boyd, R. N., Stevenson, R. D., Ware, R. S., Keawutan, P., Benfer, K. A., & Bell, K. L. (2016). Longitudinal Growth, Diet, and Physical Activity in Young Children With Cerebral Palsy. Pediatrics, 138(4), e20161321.

Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. (2013) An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. (2013) 55:509–19.

Öcal G, Şıklar Z, S: Puberte fizyolojisi. İç: Çinaz P, Darendeliler F, Akinci A, Özkan B, Dindar BN, Abacı A, Akçay T ed. Çocuk Endokrinolojisi. 1. baskı Ankara Nobel ; 2013: 153,165

Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997). Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental medicine and child neurology, 39(4), 214–223

Palmert, M. R., & Dunkel, L. (2012). Clinical practice. Delayed puberty. The New England journal of medicine, 366(5), 443–453.

Quint, E. H., O’Brien, R. F., COMMITTEE ON ADOLESCENCE, & North American Society for Pediatric and Adolescent Gynecology (2016). Menstrual Management for Adolescents With Disabilities. Pediatrics, 138(1), e20160295.

Rhodes, L. N., Diaz-Thomas, A., Woodland, W. H., Sawyer, J. R., Spence, D. D., & Warner, W. C., Jr (2024). Assessment and management of low bone mineral density in children with cerebral palsy. Journal of the Pediatric Orthopaedic Society of North America, 7, 100060.

Robert Koch Institute. Reference Percentiles for Anthropometric Measures and Blood Pressure Based on the German Health Interview and Examination Survey for Children and Adolescents 2003-2006 KiGGS Abridged English Translation (2016)

Robertson, C. M., Morrish, D. W., Wheler, G. H., & Grace, M. G. (1990). Neonatal encephalopathy: an indicator of early sexual maturation in girls. Pediatric neurology, 6(2), 102–108.

Ruiz Brunner, M. L. M., Cuestas, E., Heinen, F., & Schroeder, A. S. (2022). Growth in infants, children and adolescents with unilateral and bilateral cerebral palsy. Scientific reports, 12(1), 1879.

Rundle, J. S., Primrose, D. A., & Carachi, R. (1982). Cryptorchism in cerebral palsy. British journal of urology, 54(2), 170–171.

Samson-Fang, L., & Bell, K. L. (2013). Assessment of growth and nutrition in children with cerebral palsy. European journal of clinical nutrition, 67 Suppl 2, S5–S8.

Scarpato, E., Staiano, A., Molteni, M., Terrone, G., Mazzocchi, A., & Agostoni, C. (2017). Nutritional assessment and intervention in children with cerebral palsy: a practical approach. International journal of food sciences and nutrition, 68(6), 763–770

Sees, J. P., Sitoula, P., Dabney, K., Holmes, L., Jr, Rogers, K. J., Kecskemethy, H. H., Bachrach, S., & Miller, F. (2016). Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. Journal of pediatric orthopedics, 36(2), 193–197.

Shaw N. J. (2008). Management of osteoporosis in children. European journal of endocrinology, 159 Suppl 1, S33–S39.

Shim, M. L., Moshang, T., Jr, Oppenheim, W. L., & Cohen, P. (2004). Is treatment with growth hormone effective in children with cerebral palsy?. Developmental medicine and child neurology. 46(8), 569-571

Siddiqi, S. U., Van Dyke, D. C., Donohoue, P., & McBrien, D. M. (1999). Premature sexual development in individuals with neurodevelopmental disabilities. Developmental medicine and child neurology, 41(6), 392–395.

Siddiqui, J. A., & Partridge, N. C. (2016). Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology (Bethesda, Md.), 31(3), 233–245.

Smith, J. A., Hutson, J. M., Beasley, S. W., & Reddihough, D. S. (1989). The relationship between cerebral palsy and cryptorchidism. Journal of pediatric surgery, 24(12), 1303–1305.

Stallings, V. A., Zemel, B. S., Davies, J. C., Cronk, C. E., & Charney, E. B. (1996). Energy expenditure of children and adolescents with severe disabilities: a cerebral palsy model. The American journal of clinical nutrition, 64(4), 627–634.

Stevenson, R. D., Hayes, R. P., Cater, L. V., & Blackman, J. A. (1994). Clinical correlates of linear growth in children with cerebral palsy. Developmental medicine and child neurology, 36(2), 135–142.

Stevenson, R. D., Conaway, M., Barrington, J. W., Cuthill, S. L., Worley, G., & Henderson, R. C. (2006). Fracture rate in children with cerebral palsy. Pediatric rehabilitation, 9(4), 396–403.

Stevenson, R. D., Conaway, M., Chumlea, W. C., Rosenbaum, P., Fung, E. B., Henderson, R. C., Worley, G., Liptak, G., O’Donnell, M., Samson-Fang, L., Stallings, V. A., & North American Growth in Cerebral Palsy Study (2006). Growth and health in children with moderate-to-severe cerebral palsy. Pediatrics, 118(3), 1010–1018.

Strand, K. M., Dahlseng, M. O., Lydersen, S., Rø, T. B., Finbråten, A. K., Jahnsen, R. B., Andersen, G. L., & Vik, T. (2016). Growth during infancy and early childhood in children with cerebral palsy: a population-based study. Developmental medicine and child neurology, 58(9), 924–930.

Strandjord, R. E., Aanderud, S., Myking, O. L., & Johannessen, S. I. (1981). Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy. Acta neurologica Scandinavica, 63(2), 111–121.

Sullivan, P. B., Alder, N., Bachlet, A. M., Grant, H., Juszczak, E., Henry, J., Vernon-Roberts, A., Warner, J., & Wells, J. (2006). Gastrostomy feeding in cerebral palsy: too much of a good thing?. Developmental medicine and child neurology, 48(11), 877–882.

Svalheim, S., Sveberg, L., Mochol, M., & Taubøll, E. (2015). Interactions between antiepileptic drugs and hormones. Seizure, 28, 12–17.

Şen, E. K., Berberoğlu, M., Şenyazar, G., Kızılcan Çetin, S., Ceran, A., Erişen Karaca, S., Özsu, E., Aycan, Z., & Şıklar, Z. (2024). Assessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis. Journal of clinical research in pediatric endocrinology, 16(4), 466–474.

Taubøll, E., Gregoraszczuk, E. L., Wojtowicz, A. K., & Milewicz, T. (2009). Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells. Epilepsia, 50(8), 1868–1874.

Tiihonen, M., Liewendahl, K., Waltimo, O., Ojala, M., & Välimäki, M. (1995). Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia, 36(11), 1118–1125.

Uday, S., Shaw, N., Krone, R., & Kirk, J. (2017). Hypopituitarism in children with cerebral palsy. Archives of disease in childhood, 102(6), 559-561

Uddenfeldt Wort, U., Nordmark, E., Wagner, P., Düppe, H., & Westbom, L. (2013). Fractures in children with cerebral palsy: a total population study. Developmental medicine and child neurology, 55(9), 821–826.

United States Medical Eligibility Criteria (US MEC) for Contraceptive Use. 2010. Available at: www.cdc. gov/ reproductivehealt h/unintendedpregnan cy/ usmec. htm.Accessed May 4, 2015

Vainionpää, L. K., Rättyä, J., Knip, M., Tapanainen, J. S., Pakarinen, A. J., Lanning, P., Tekay, A., Myllylä, V. V., & Isojärvi, J. I. (1999). Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of neurology, 45(4), 444–450.

Verrotti, A., Laus, M., Scardapane, A., Franzoni, E., & Chiarelli, F. (2009). Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. European journal of endocrinology, 160(1), 81–86.

Ward L. M. (2021). Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?. Current osteoporosis reports, 19(3), 278–288.

Wimalasundera, N., & Stevenson, V. L. (2016). Cerebral palsy. Practical neurology, 16(3), 184–194.

Worley, G., Houlihan, C. M., Herman-Giddens, M. E., O’Donnell, M. E., Conaway, M., Stallings, V. A., Chumlea, W. C., Henderson, R. C., Fung, E. B., Rosenbaum, P. L., Samson-Fang, L., Liptak, G. S., Calvert, R. E., & Stevenson, R. D. (2002). Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics, 110(5), 897–902.

World Health Organization. Technical Consultation on the Effects of Hormonal Contraception on Bone Health: Summary Report. Geneva, Switzerland: World Health Organization: 2005. Available at: http:// whqlibdoc. who. int/ hq/ 2007/ WHO_ RHR_ 07. 08_ eng.pdf. Accessed May 4, 2015

Yaşar, E., Adigüzel, E., Arslan, M., & Matthews, D. J. (2018). Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 22(1), 17–26

Yılmaz, U., Yılmaz, T. S., Akıncı, G., Korkmaz, H. A., & Tekgül, H. (2014). The effect of antiepileptic drugs on thyroid function in children. Seizure, 23(1), 29–35.

Zacharin M. (2013). Endocrine problems in children and adolescents who have disabilities. Hormone research in paediatrics, 80(4), 221–228.

Zacharin M. R. (2009). Puberty, contraception, and hormonal management for young people with disabilities. Clinical pediatrics, 48(2), 149–155.

Zemel, B. S., Leonard, M. B., Kelly, A., Lappe, J. M., Gilsanz, V., Oberfield, S., Mahboubi, S., Shepherd, J. A., Hangartner, T. N., Frederick, M. M., Winer, K. K., & Kalkwarf, H. J. (2010). Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. The Journal of clinical endocrinology and metabolism, 95(3), 1265–1273.